Laura Calosi

TL;DR: MnL4 appears as a novel protective compound potentially suitable for the treatment of joint diseases by behaving as a potent pain reliever in acute inflammatory and chronic articular pain.

TL;DR: The proposal that PARP inhibitors could have a therapeutic potential in reducing the progression of signs and symptoms of the disease by decreasing T GF‐β expression and the TGF‐β/SMAD transduction pathway is supported.

TL;DR: Glucagon‐like peptide‐2 (GLP‐2) is a pleiotropic hormone synthesized and secreted by the enteroendocrine ‘L’ cells able to exert intestine‐trophic and anti‐inflammatory effects.

TL;DR: It is demonstrated that RLX is capable of counteracting CS‐mediated vascular damage and dysfunction by reducing oxidative stress, thus adding a tile to the growing mosaic of the beneficial effects of RLX in CVD.

TL;DR: In this paper, the early response of Dendritic cells to skin wounding has been investigated in humans, and the results suggest that skin dendritic cell including Langerhans cells, including mast cells, participate to early response to wounding in concert with mast cells and that subpapillary blood vessels are primary sites of cell infiltration during that response in humans.